Becton Dickinson and Co vs MPLX LP — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while MPLX LP trades at $59.35 (market cap $60.12B). The key difference: MPLX LP is the larger of the two by market cap, and MPLX LP pays the higher dividend (7.26%). Which is the better fit depends on your goals.
| BDX | MPLX | |
|---|---|---|
Market Cap | $49.41B | $60.12B |
Sector | Health | Technology |
52-Week High | $185.39 | $60.51 |
52-Week Low | $138.62 | $47.80 |
Enterprise Value | $65.51B | $85.22B |
Dividend Yield | 2.32% | 7.26% |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →